[HTML][HTML] Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation
TT Pham, B Whelan, BM Oborn, GP Delaney… - Radiotherapy and …, 2022 - Elsevier
Proton therapy and MRI-Linacs are two of the most exciting and fast growing technologies in
radiation oncology. With over 100 MRI-Linacs and 100 proton therapy centres either in …
radiation oncology. With over 100 MRI-Linacs and 100 proton therapy centres either in …
The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective
KH Wong, R Panek, SA Bhide… - The British Journal of …, 2017 - academic.oup.com
Head and neck cancer (HNC) is a challenging tumour site for radiotherapy delivery owing to
its complex anatomy and proximity to organs at risk (OARs) such as the spinal cord and optic …
its complex anatomy and proximity to organs at risk (OARs) such as the spinal cord and optic …
Multicenter evaluation of MRI‐based radiomic features: A phantom study
Introduction This work describes the development of a novel radiomics phantom designed
for magnetic resonance imaging (MRI) that can be used in a multicenter setting. The …
for magnetic resonance imaging (MRI) that can be used in a multicenter setting. The …
Arterial spin labelling and diffusion-weighted magnetic resonance imaging in differentiation of recurrent head and neck cancer from post-radiation changes
AAKA Razek - The Journal of Laryngology & Otology, 2018 - cambridge.org
ObjectiveTo assess arterial spin labelling and diffusion-weighted imaging in the
differentiation of recurrent head and neck cancer from post-radiation changes. MethodsA …
differentiation of recurrent head and neck cancer from post-radiation changes. MethodsA …
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck …
Objective To assess the optimal timing and predictive value of early intra-treatment changes
in multimodality functional and molecular imaging (FMI) parameters as biomarkers for …
in multimodality functional and molecular imaging (FMI) parameters as biomarkers for …
Clinical-radiomics nomograms for pre-operative differentiation of sacral chordoma and sacral giant cell tumor based on 3D computed tomography and multiparametric …
P Yin, N Mao, S Wang, C Sun… - The British Journal of …, 2019 - academic.oup.com
Objective: To develop and validate clinical-radiomics nomograms based on three-
dimensional CT and multiparametric MRI (mpMRI) for pre-operative differentiation of sacral …
dimensional CT and multiparametric MRI (mpMRI) for pre-operative differentiation of sacral …
Adaptive radiotherapy for head and neck cancer: are we ready to put it into routine clinical practice?
MF Gensheimer, QT Le - Oral Oncology, 2018 - Elsevier
Patients with head and neck cancer who are treated with radiotherapy often have significant
weight loss or tumor regression during treatment. Adaptive radiotherapy refers to acquiring …
weight loss or tumor regression during treatment. Adaptive radiotherapy refers to acquiring …
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
N Wiedenmann, H Bunea, HC Rischke, A Bunea… - Radiation …, 2018 - Springer
Background To assess the effect of radiochemotherapy (RCT) on proposed tumour hypoxia
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18 F …
marker transverse relaxation time (T2*) and to analyse the relation between T2* and 18 F …
Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging …
Purpose To evaluate the prognostic value of 18 F-FDG-PET-CT performed prior to (prePET)
and during the third week (iPET) of radiation therapy (RT) in nasopharyngeal carcinoma …
and during the third week (iPET) of radiation therapy (RT) in nasopharyngeal carcinoma …
[HTML][HTML] Impact of tumour region of interest delineation method for mid-treatment FDG-PET response prediction in head and neck squamous cell carcinoma …
Y Trada, P Lin, MT Lee, MG Jameson… - … Imaging in Medicine …, 2023 - ncbi.nlm.nih.gov
Background The aim of this study was to evaluate the impact of tumour region of interest
(ROI) delineation method on mid-treatment 18 F-fluoro-2-deoxy-D-glucose positron …
(ROI) delineation method on mid-treatment 18 F-fluoro-2-deoxy-D-glucose positron …